Suppr超能文献

75%肾切除术和 2,3-二巯基丙磺酸处理的缺乏功能性多药耐药蛋白 2 的大鼠中无机汞的处置。

Seventy-five percent nephrectomy and the disposition of inorganic mercury in 2,3-dimercaptopropanesulfonic acid-treated rats lacking functional multidrug-resistance protein 2.

机构信息

Division of Basic Medical Sciences, Mercer University School of Medicine, 1550 College Street, Macon, GA 31207, USA.

出版信息

J Pharmacol Exp Ther. 2010 Mar;332(3):866-75. doi: 10.1124/jpet.109.163774. Epub 2009 Dec 23.

Abstract

In the present study, we evaluated the disposition of inorganic mercury (Hg(2+)) in sham-operated and 75% nephrectomized (NPX) Wistar and transport-deficient (TR(-)) rats treated with saline or the chelating agent meso-2,3-dimercaptosuccinic acid (DMSA). Based on previous studies, DMSA and TR(-) rats were used as tools to examine the potential role of multidrug-resistance protein 2 (MRP2) in the disposition of Hg(2+) during renal insufficiency. All animals were treated with a low dose (0.5 mumol/kg i.v.) of mercuric chloride (HgCl(2)). At 24 and 28 h after exposure to HgCl(2), matched groups of Wistar and TR(-) rats received normal saline or DMSA (intraperitoneally). Forty-eight hours after exposure to HgCl(2), the disposition of Hg(2+) was examined. A particularly notable effect of 75% nephrectomy in both strains of rats was enhanced renal accumulation of Hg(2+), specifically in the outer stripe of the outer medulla. In addition, hepatic accumulation, fecal excretion, and blood levels of Hg(2+) were enhanced in rats after 75% nephrectomy, especially in the TR(-) rats. Treatment with DMSA increased both the renal tubular elimination and urinary excretion of Hg(2+) in all rats. DMSA did not, however, affect hepatic content of Hg(2+), even in the 75% NPX TR(-) rats. We also show with real-time polymerase chain reaction that after 75% nephrectomy and compensatory renal growth, expression of MRP2 (only in Wistar rats) and organic anion transporter 1 is enhanced in the remaining functional proximal tubules. We conclude that MRP2 plays a significant role in the renal and corporal disposition of Hg(2+) after a 75% reduction of renal mass.

摘要

在本研究中,我们评估了假手术和 75%肾切除(NPX)Wistar 以及转运缺陷(TR(-))大鼠中无机汞(Hg(2+))的处置情况,这些大鼠分别用盐水或螯合剂 meso-2,3-二巯基丁二酸(DMSA)处理。基于之前的研究,DMSA 和 TR(-)大鼠被用作工具,以研究多药耐药相关蛋白 2(MRP2)在肾功能不全期间对 Hg(2+)处置的潜在作用。所有动物均接受低剂量(0.5 mumol/kg 静脉内)氯化汞(HgCl(2))处理。暴露于 HgCl(2)后 24 和 28 小时,匹配的 Wistar 和 TR(-)大鼠组接受生理盐水或 DMSA(腹腔内)处理。暴露于 HgCl(2)后 48 小时,检查 Hg(2+)的处置情况。75%肾切除对两种大鼠的特别显著影响是增强了 Hg(2+)在肾脏的蓄积,特别是在外髓外层。此外,75%肾切除后大鼠的肝蓄积、粪便排泄和血液 Hg(2+)水平增加,尤其是在 TR(-)大鼠中。DMSA 处理增加了所有大鼠的肾小管清除率和尿 Hg(2+)排泄。然而,DMSA 并未影响肝中 Hg(2+)含量,即使在 75% NPX TR(-)大鼠中也是如此。我们还通过实时聚合酶链反应显示,在 75%肾切除和代偿性肾生长后,MRP2(仅在 Wistar 大鼠中)和有机阴离子转运蛋白 1 的表达在剩余的功能性近端肾小管中增强。我们得出结论,MRP2 在 75%肾质量减少后对 Hg(2+)的肾和 corporal 处置中起重要作用。

相似文献

5
MRP2 and the handling of mercuric ions in rats exposed acutely to inorganic and organic species of mercury.
Toxicol Appl Pharmacol. 2011 Feb 15;251(1):50-8. doi: 10.1016/j.taap.2010.11.015. Epub 2010 Dec 4.
6
MRP2 involvement in renal proximal tubular elimination of methylmercury mediated by DMPS or DMSA.
Toxicol Appl Pharmacol. 2009 Feb 15;235(1):10-7. doi: 10.1016/j.taap.2008.11.003. Epub 2008 Nov 19.
8
Reductions in renal mass and the nephropathy induced by mercury.
Toxicol Appl Pharmacol. 1997 Apr;143(2):366-79. doi: 10.1006/taap.1996.8084.
9
Progressive losses of renal mass and the renal and hepatic disposition of administered inorganic mercury.
Toxicol Appl Pharmacol. 1995 Jan;130(1):121-31. doi: 10.1006/taap.1995.1016.

引用本文的文献

1
Molecular Mechanisms of Cellular Injury and Role of Toxic Heavy Metals in Chronic Kidney Disease.
Int J Mol Sci. 2022 Sep 21;23(19):11105. doi: 10.3390/ijms231911105.
2
Chronic Kidney Disease and Exposure to Nephrotoxic Metals.
Int J Mol Sci. 2017 May 12;18(5):1039. doi: 10.3390/ijms18051039.
3
Relationships between the renal handling of DMPS and DMSA and the renal handling of mercury.
Chem Res Toxicol. 2012 Sep 17;25(9):1825-38. doi: 10.1021/tx3001847. Epub 2012 Jun 15.

本文引用的文献

1
Regulation of amino acid transporters in the rat remnant kidney.
Nephrol Dial Transplant. 2009 Jul;24(7):2058-67. doi: 10.1093/ndt/gfn752. Epub 2009 Jan 20.
2
MRP2 involvement in renal proximal tubular elimination of methylmercury mediated by DMPS or DMSA.
Toxicol Appl Pharmacol. 2009 Feb 15;235(1):10-7. doi: 10.1016/j.taap.2008.11.003. Epub 2008 Nov 19.
6
Disposition and sterol-lowering effect of ezetimibe in multidrug resistance-associated protein 2-deficient rats.
J Pharmacol Exp Ther. 2006 Sep;318(3):1293-9. doi: 10.1124/jpet.106.104018. Epub 2006 Jun 13.
7
Handling of cysteine S-conjugates of methylmercury in MDCK cells expressing human OAT1.
Kidney Int. 2005 Oct;68(4):1684-99. doi: 10.1111/j.1523-1755.2005.00585.x.
9
Homocysteine, system b0,+ and the renal epithelial transport and toxicity of inorganic mercury.
Am J Pathol. 2004 Oct;165(4):1385-94. doi: 10.1016/S0002-9440(10)63396-2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验